Monopar Corp (MNPR): Price Chart

The historical price action of Monopar Therapeutics (MNPR) on the GURU.Markets platform is currently at 72.07. The business focuses on developing advanced radiation therapies for tumors aimed at reducing toxicity. Risks are mitigated by distributing research across various types of solid neoplasms. Meanwhile, a lean executive team ensures agility in seeking partners, although market confidence remains heavily dependent on test results.

Quote Chart: Monopar Therapeutics (MNPR) for 07/04/2022 - 11/14/2026

MNPR (Monopar Pharma): analytical breakdowns and indicator data

- stock value and consensus price forecast:

Price Chart Monopar Therapeutics Inc|MNPR - Consensus Target

- stock exchange capitalization data:

Market Value Monopar Therapeutics Inc.|MNPR - Business Value

- balance sheet equity data:

Net Assets per Single Share Monopar Therapeutics|MNPR - Net Asset Value|Market Value to Book Value Ratio monopartx.com|MNPR - Aggregate Asset Value

- business debt structure and liquidity details:

Total Debt to Capital Monopar Therapeutics|MNPR - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Monopar Therapeutics Inc|MNPR - Company Cumulative Debt|Debt to Book Capitalization Ratio Monopar Therapeutics Inc.|MNPR - Company Long-Term Indebtedness|Company Short-Term Debts Monopar Therapeutics|Quick Liquidity monopartx.com

- company profitability and valuation multiples indicators:

MNPR - Final Profit|Projected Future Earnings Monopar Therapeutics|MNPR - P/E Multiple|Future Price to Earnings Monopar Pharma|MNPR - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Monopar Therapeutics|MNPR - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Monopar Therapeutics|MNPR - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months monopartx.com|MNPR - Earnings per share growth this year|Earnings growth forecast for next year Monopar Therapeutics

- sales and revenue indicators:

MNPR - Company Sales|Company Projected Revenue Monopar Corp|MNPR - Price to Sales|Price-to-Projected Revenue Ratio Monopar Corp

Analysis of all company metrics:MNPR Monopar Pharma

Price represents the market equivalent of an asset's value, aggregating all fundamental data and investor expectations into a single digital coefficient. When analyzing the market fluctuations of Monopar Therapeutics (MNPR), it is essential to consider that volatility here directly reflects confidence in the efficiency of external infrastructure, as the total dependence of Monopar Therapeutics on third-party laboratories makes quotes extremely sensitive to news regarding the progress of outsourced clinical trials.

Who Monopar Therapeutics competes with